Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Impact of risk minimisation measures on the use of strontium ranelate: A multinational cohort study in 5 EU countries by the EU-ADR Alliance

Conference paper

Berencsi K. et al, (2018), Pharmacoepidemiology and drug safety, 27, 189 - 189

Pathophysiology-based phenotyping in type 2 diabetes: A clinical classification tool.

Journal article

Stidsen JV. et al, (2018), Diabetes metab res rev, 34

Impact of Risk Minimisation Measures on the Use of Strontium Ranelate: A Multi-National Cohort Study in 5 EU Countries by the EU-ADR Alliance

Conference paper

Berencsi K. et al, (2017), Pharmacoepidemiology and drug safety, 26, 483 - 483

Load More